跳至主要内容
临床试验/TCTR20170629004
TCTR20170629004已完成3 期

The Efficiency of Furosemide, Salt tablet and Fluid restriction for Long-term Treatment of Patients with Syndrome of Inappropriate Antidiuresis (SIAD): A Double-blinded Randomized Controlled Trial

Renal Division, Department of Internal Medicine, Chiang Mai University0 个研究点目标入组 90 人开始时间: 2017年6月29日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 0 N/A (No limit)(—)
性别
All

入选标准

  • - Age of more than 18 years old
  • - Serum sodium ≤130 mmol/L
  • - Chronic hyponatremia (>48 hour after onset or unknown onset)
  • - Diagnosis of SIAD, all following criterion must be met:
  • - Effective serum osmolality<275 mOsm/kg
  • - Urine osmolality >100 mOsm/kg H2O
  • - Clinical euvolemia
  • - Urine sodium concentration >30 mmol/L with normal dietary salt and water intake
  • - Absence of hypothyroidism (thyroid-stimulating hormone <10 mIU/mL), glucocorticoid deficiency (unstimulated or stimulated cortisol level 10 ug/dL or) and significant renal insufficiency (define as serum creatinine > 1.2 or diagnosed as acute kidney injury)

排除标准

  • - Clinical overt hypovolemia or hypervolemia
  • - Decompensated liver cirrhosis, symptomatic heart failure, and nephrotic syndrome
  • - Hemodynamic unstable
  • - Current using investigational agents (salt tablet or furosemide), other diuretics and steroids
  • - Severe symptomatic hyponatremia at diagnosis (defined as vomiting, cardiorespiratory distress, abnormal and deep somnolence, seizures, and coma (which define as Glasgow Coma Scale 8)
  • - Hyperglycemia enough to interfere with assessment of serum sodium, defined as random plasma glucose >300 mg/dL at the time of diagnosis
  • - Receiving renal replacement therapy
  • - Post kidney transplant status
  • - Furosemide allergy
  • - Contraindicated for eating or feeding via enteral route

研究者

发起方
Renal Division&#44; Department of Internal Medicine&#44; Chiang Mai University

相似试验